Modulation of Acid Sphingomyelinase in Melanoma Reprogrammes the Tumour Immune Microenvironment

The inflammatory microenvironment induces tumours to acquire an aggressive and immunosuppressive behaviour. Since acid sphingomyelinase (A-SMase) downregulation in melanoma was shown to determine a malignant phenotype, we aimed here to elucidate the role of A-SMase in the regulation of tumour immuno...

Full description

Saved in:
Bibliographic Details
Main Authors: Emma Assi, Davide Cervia, Laura Bizzozero, Annalisa Capobianco, Sarah Pambianco, Federica Morisi, Clara De Palma, Claudia Moscheni, Paolo Pellegrino, Emilio Clementi, Cristiana Perrotta
Format: Article
Language:English
Published: Wiley 2015-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2015/370482
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832552875606147072
author Emma Assi
Davide Cervia
Laura Bizzozero
Annalisa Capobianco
Sarah Pambianco
Federica Morisi
Clara De Palma
Claudia Moscheni
Paolo Pellegrino
Emilio Clementi
Cristiana Perrotta
author_facet Emma Assi
Davide Cervia
Laura Bizzozero
Annalisa Capobianco
Sarah Pambianco
Federica Morisi
Clara De Palma
Claudia Moscheni
Paolo Pellegrino
Emilio Clementi
Cristiana Perrotta
author_sort Emma Assi
collection DOAJ
description The inflammatory microenvironment induces tumours to acquire an aggressive and immunosuppressive behaviour. Since acid sphingomyelinase (A-SMase) downregulation in melanoma was shown to determine a malignant phenotype, we aimed here to elucidate the role of A-SMase in the regulation of tumour immunogenic microenvironment using in vivo melanoma models in which A-SMase was either downregulated or maintained at constitutively high levels. We found high levels of inflammatory factors in low A-SMase expressing tumours, which also displayed an immunosuppressive/protumoural microenvironment: high levels of myeloid-derived suppressor cells (MDSCs) and regulatory T lymphocytes (Tregs), as well as low levels of dendritic cells (DCs). In contrast, the restoration of A-SMase in melanoma cells not only reduced tumour growth and immunosuppression, but also induced a high recruitment at tumour site of effector immune cells with an antitumoural function. Indeed, we observed a poor homing of MDSCs and Tregs and the increased recruitment of CD8+ and CD4+ T lymphocytes as well as the infiltration of DCs and CD8+/CD44high T lymphocytes. This study demonstrates that change of A-SMase expression in cancer cells is sufficient per se to tune in vivo melanoma growth and that A-SMase levels modulate immune cells at tumour site. This may be taken into consideration in the setting of therapeutic strategies.
format Article
id doaj-art-b30b3bbe561a4f39882c46a9a0863004
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2015-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-b30b3bbe561a4f39882c46a9a08630042025-02-03T05:57:40ZengWileyMediators of Inflammation0962-93511466-18612015-01-01201510.1155/2015/370482370482Modulation of Acid Sphingomyelinase in Melanoma Reprogrammes the Tumour Immune MicroenvironmentEmma Assi0Davide Cervia1Laura Bizzozero2Annalisa Capobianco3Sarah Pambianco4Federica Morisi5Clara De Palma6Claudia Moscheni7Paolo Pellegrino8Emilio Clementi9Cristiana Perrotta10Scientific Institute IRCCS Eugenio Medea, 23842 Bosisio Parini, ItalyUnit of Clinical Pharmacology, National Research Council-Institute of Neuroscience, Department of Biomedical and Clinical Sciences “Luigi Sacco” (DIBIC), University Hospital “Luigi Sacco”, Università di Milano, 20157 Milan, ItalyScientific Institute IRCCS Eugenio Medea, 23842 Bosisio Parini, ItalyDivision of Regenerative Medicine, San Raffaele Scientific Institute, 20132 Milan, ItalyUnit of Clinical Pharmacology, National Research Council-Institute of Neuroscience, Department of Biomedical and Clinical Sciences “Luigi Sacco” (DIBIC), University Hospital “Luigi Sacco”, Università di Milano, 20157 Milan, ItalyUnit of Clinical Pharmacology, National Research Council-Institute of Neuroscience, Department of Biomedical and Clinical Sciences “Luigi Sacco” (DIBIC), University Hospital “Luigi Sacco”, Università di Milano, 20157 Milan, ItalyUnit of Clinical Pharmacology, National Research Council-Institute of Neuroscience, Department of Biomedical and Clinical Sciences “Luigi Sacco” (DIBIC), University Hospital “Luigi Sacco”, Università di Milano, 20157 Milan, ItalyUnit of Morphology, Department of Biomedical and Clinical Sciences “Luigi Sacco” (DIBIC), Università di Milano, 20157 Milan, ItalyUnit of Clinical Pharmacology, National Research Council-Institute of Neuroscience, Department of Biomedical and Clinical Sciences “Luigi Sacco” (DIBIC), University Hospital “Luigi Sacco”, Università di Milano, 20157 Milan, ItalyScientific Institute IRCCS Eugenio Medea, 23842 Bosisio Parini, ItalyUnit of Clinical Pharmacology, National Research Council-Institute of Neuroscience, Department of Biomedical and Clinical Sciences “Luigi Sacco” (DIBIC), University Hospital “Luigi Sacco”, Università di Milano, 20157 Milan, ItalyThe inflammatory microenvironment induces tumours to acquire an aggressive and immunosuppressive behaviour. Since acid sphingomyelinase (A-SMase) downregulation in melanoma was shown to determine a malignant phenotype, we aimed here to elucidate the role of A-SMase in the regulation of tumour immunogenic microenvironment using in vivo melanoma models in which A-SMase was either downregulated or maintained at constitutively high levels. We found high levels of inflammatory factors in low A-SMase expressing tumours, which also displayed an immunosuppressive/protumoural microenvironment: high levels of myeloid-derived suppressor cells (MDSCs) and regulatory T lymphocytes (Tregs), as well as low levels of dendritic cells (DCs). In contrast, the restoration of A-SMase in melanoma cells not only reduced tumour growth and immunosuppression, but also induced a high recruitment at tumour site of effector immune cells with an antitumoural function. Indeed, we observed a poor homing of MDSCs and Tregs and the increased recruitment of CD8+ and CD4+ T lymphocytes as well as the infiltration of DCs and CD8+/CD44high T lymphocytes. This study demonstrates that change of A-SMase expression in cancer cells is sufficient per se to tune in vivo melanoma growth and that A-SMase levels modulate immune cells at tumour site. This may be taken into consideration in the setting of therapeutic strategies.http://dx.doi.org/10.1155/2015/370482
spellingShingle Emma Assi
Davide Cervia
Laura Bizzozero
Annalisa Capobianco
Sarah Pambianco
Federica Morisi
Clara De Palma
Claudia Moscheni
Paolo Pellegrino
Emilio Clementi
Cristiana Perrotta
Modulation of Acid Sphingomyelinase in Melanoma Reprogrammes the Tumour Immune Microenvironment
Mediators of Inflammation
title Modulation of Acid Sphingomyelinase in Melanoma Reprogrammes the Tumour Immune Microenvironment
title_full Modulation of Acid Sphingomyelinase in Melanoma Reprogrammes the Tumour Immune Microenvironment
title_fullStr Modulation of Acid Sphingomyelinase in Melanoma Reprogrammes the Tumour Immune Microenvironment
title_full_unstemmed Modulation of Acid Sphingomyelinase in Melanoma Reprogrammes the Tumour Immune Microenvironment
title_short Modulation of Acid Sphingomyelinase in Melanoma Reprogrammes the Tumour Immune Microenvironment
title_sort modulation of acid sphingomyelinase in melanoma reprogrammes the tumour immune microenvironment
url http://dx.doi.org/10.1155/2015/370482
work_keys_str_mv AT emmaassi modulationofacidsphingomyelinaseinmelanomareprogrammesthetumourimmunemicroenvironment
AT davidecervia modulationofacidsphingomyelinaseinmelanomareprogrammesthetumourimmunemicroenvironment
AT laurabizzozero modulationofacidsphingomyelinaseinmelanomareprogrammesthetumourimmunemicroenvironment
AT annalisacapobianco modulationofacidsphingomyelinaseinmelanomareprogrammesthetumourimmunemicroenvironment
AT sarahpambianco modulationofacidsphingomyelinaseinmelanomareprogrammesthetumourimmunemicroenvironment
AT federicamorisi modulationofacidsphingomyelinaseinmelanomareprogrammesthetumourimmunemicroenvironment
AT claradepalma modulationofacidsphingomyelinaseinmelanomareprogrammesthetumourimmunemicroenvironment
AT claudiamoscheni modulationofacidsphingomyelinaseinmelanomareprogrammesthetumourimmunemicroenvironment
AT paolopellegrino modulationofacidsphingomyelinaseinmelanomareprogrammesthetumourimmunemicroenvironment
AT emilioclementi modulationofacidsphingomyelinaseinmelanomareprogrammesthetumourimmunemicroenvironment
AT cristianaperrotta modulationofacidsphingomyelinaseinmelanomareprogrammesthetumourimmunemicroenvironment